Valuation: AtriCure, Inc.

Market Cap 2.94B 2.62B 2.44B 2.22B 4.17B 278B 4.25B 29.29B 11.46B 145B 11.03B 10.8B 465B P/E 2026 *
541x
P/E 2027 * 137x
Enterprise Value 2.79B 2.49B 2.31B 2.1B 3.96B 264B 4.03B 27.77B 10.87B 138B 10.46B 10.24B 441B EV / Sales 2026 *
4.6x
EV / Sales 2027 * 3.99x
Free-Float
96.24%
Yield 2026 *
-
Yield 2027 * -
1 day-1.58%
1 week+2.25%
Current month+1.54%
1 month-0.13%
3 months+60.20%
6 months+97.59%
Current year+44.25%
1 week 55.67
Extreme 55.67
58.44
1 month 51.63
Extreme 51.63
61.7
Current year 25.36
Extreme 25.36
61.7
1 year 25.36
Extreme 25.36
61.7
3 years 18.94
Extreme 18.94
61.7
5 years 18.94
Extreme 18.94
89.18
10 years 14.78
Extreme 14.78
89.18
Manager TitleAgeSince
Chief Executive Officer 55 2012-11-01
Director of Finance/CFO 48 2014-06-30
Chief Tech/Sci/R&D Officer 59 2017-07-17
Director TitleAgeSince
Director/Board Member 55 2012-11-01
Director/Board Member 64 2013-03-10
Director/Board Member 75 2016-11-09
Date Insider Type Main position Quantity % Market Cap. Importance
9/23/26 Sell

Chief Technology Officer

-4,519 0.0089%
9/11/26 Sell

Director

-5,313 0.0104%
9/8/26 Sell

Chief Technology Officer

-3,657 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-1.40%+2.25%+53.24%+54.69% 2.94B
+0.11%+5.40%-17.75%+13.89% 181B
-0.13%+7.57%+0.15%+32.66% 117B
+0.75%+6.85%-19.75%+12.20% 112B
+2.66%+4.30%-44.81%-7.83% 76.56B
-0.21%+5.50%+6.97%+82.84% 65.15B
+2.79%+2.37%+15.93%+68.64% 52.79B
-0.30%+5.38%+4.52%-25.45% 52.78B
+2.00%+7.48%-12.65%+29.61% 43.11B
-0.21%+0.97% - - 32.08B
Average +0.57%+5.49%-1.57%+29.03% 73.59B
Weighted average by Cap. +0.63%+5.72%-10.95%+23.04%

Financials

2026 *2027 *
Net sales 606M 541M 503M 457M 861M 57.42B 876M 6.04B 2.36B 29.96B 2.28B 2.23B 95.87B 680M 607M 564M 513M 965M 64.38B 982M 6.77B 2.65B 33.59B 2.55B 2.5B 107B
Net income 7.13M 6.37M 5.92M 5.38M 10.13M 676M 10.31M 71.08M 27.81M 352M 26.77M 26.2M 1.13B 20.89M 18.64M 17.33M 15.76M 29.65M 1.98B 30.19M 208M 81.44M 1.03B 78.38M 76.72M 3.3B
Net Debt -152M -136M -126M -115M -216M -14.39B -220M -1.51B -592M -7.51B -570M -558M -24.02B -227M -202M -188M -171M -322M -21.46B -327M -2.26B -883M -11.2B -850M -832M -35.83B
Projected Income Statement - Annual - AtriCure, Inc.
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
26-10-16 US$57.07 -1.24% 54,203
26-10-15 US$57.78 +0.84% 850,921
26-10-14 US$57.30 +0.76% 799,310
26-10-13 US$56.87 -0.72% 596,098
26-10-12 US$57.28 +2.63% 645,600
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - AtriCure, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
57.78USD
Average target price
55.78USD
Spread / Average Target
-3.47%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AtriCure, Inc.
  1. Stock Market
  2. Stocks
  3. ATRC Stock